The TLR7 agonist imiquimod induces anti-cancer effects via autophagic cell death and enhances anti-tumoral and systemic immunity during radiotherapy for melanomaJeonghyun Cho, Yu‐Jin Jung|Oncotarget|2017Cited by 96